Cannabis Pharmaceuticals Market

The cannabis pharmaceuticals market consists of medically approved, cannabis-based treatments for various conditions. The primary customers are patients suffering from chronic pain, epilepsy, anxiety, and other neurological disorders, who access these products through healthcare systems. Key growth drivers include expanding regulatory approval for medical cannabis, increasing clinical evidence of its efficacy, and rising patient demand for alternative therapeutic options.